Patents by Inventor PEREGRINE PHARMACEUTICALS, INC.

PEREGRINE PHARMACEUTICALS, INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-VEGF Antibody Compositions and Methods
    Publication number: 20130149238
    Abstract: Disclosed are human antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two primary VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present invention thus provides new human antibody-based compositions, methods and combined protocols for treating cancer and other angiogenic diseases. Advantageous immunoconjugate compositions and methods using the new VEGF-specific human antibodies are also provided.
    Type: Application
    Filed: February 15, 2013
    Publication date: June 13, 2013
    Applicants: PEREGRINE PHARMACEUTICALS, INC., AFFITECH RESEARCH AS
    Inventors: AFFITECH RESEARCH AS, PEREGRINE PHARMACEUTICALS, INC.